Our Achievements

pharma & BIOTECH

Greenfield of a blood fractionation plant in Canada

project essentials

Our teams from France, Canada and the United States worked together to design and build this greenfield fractionation plant in Canada. This project represents the largest biopharma investment in Canada.

key points

2 500 hours of engineering and studies 
14 000 hours of construction and assembly 
9 000 hours of qualification and commissioning 

equipment supplied

Manufacture and installation of 3 purification batches and 1 formulation batch

  • 24 skids
  • 30 tanks
  • Process intelligence with 17 PLCs and 30 electrical cabinets

for further information

Boccard undertook the design and manufacture of key equipment for the largest blood fractionation plant in Canada to date. The investment in this plant by Green Cross, a Korean group specializing in the manufacture of biopharma products, represents one of the largest biopharma investments in Canada.

This plant, built as part of the development of Green Cross Bio Therapeutics (GCBT), is dedicated to the manufacture of intravenous immunoglobin (IVIG) and albumin.

Boccard was chosen for its great expertise in protein purification and blood fractionation. The facility provided is state-of-the-art for plasma fractionation.

The coordination of resources was a real strength of this project: the local resources (Boccard Canada) associated with the Excellence Center (Boccard Health & Care in France) and the American teams (Boccard Life Sciences), carried out this project with an ambitious schedule of 18 months.


For Pharma & Biotech industries

Evolutive Vaccines Facility for Sanofi

Our teams are proud to have been awarded a new contract by Sanofi for carrying out mechanical installation works for the Black and Clean Utilities Lots of the Evolutive Vaccines Facility (EVF) project located in Neuville-sur-Saône (Rhône - France).

Read more
Increase production capacities in a recombinant protein production plant

In order to increase the production capacity of this Belgian biotechnology company, Boccard designed and supplied a complete unit for the production of recombinant proteins.

Read more
R&D fermentation platform for the production of hyaluronic acid

Boccard carried out the design, manufacture, qualification and commissioning of a fermentation platform with a capacity of 1000L.

Read more
Copyright Boccard 2021 / All rights reserved
CookiesLegal NoticeGDRP
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram